{"id":"F2007B01067","name":"National Health Act 1953 - Declaration under subsection 85(2AA) (No. PB 6 of 1997)","slug":"national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-6-of-1997","collection":"legislative_instrument","jurisdiction":"commonwealth","status":"repealed","isInForce":false,"actNumber":null,"makingDate":null,"administeringDepartment":null,"currentVersion":{"id":62558,"registerId":"commonwealth-F2007B01067-current","compilationNumber":null,"startDate":"2026-04-02","status":"Repealed","reasons":null,"registeredAt":null},"sections":[{"sectionNumber":"1","sectionType":"section","heading":"National Health Act 1953 - Declaration under subsection 85(2AA) (No. PB 6 of 1997)","content":"COMMONWEALTH OF AUSTRALIA\n\nNational Health Act 1953\n\nPHARMACEUTICAL BENEFITS\n\nDECLARATION UNDER SUBSECTION 85 (2AA)\n\nNo. PB 6 of 1997\n\nI, DAVID TREVOR GRAHAM, Assistant Secretary, Pharmaceutical Benefits Branch, Department of Health and Family Services and Delegate of the Minister for Health and Family Services, having in accordance with subsection 85 (2AB) of the National Health Act 1953 obtained the advice of the Pharmaceutical Benefits Advisory Committee, pursuant to subsection 85 (2AA) of the National Health Act 1953, hereby make the following Declaration:\n\n1.  This Declaration shall come into operation on 1 May 1997.\n\n2. The drugs and medicinal preparations specified in the Schedule to this Declaration shall cease to be drugs and medicinal preparations to which Part VII of the National Health Act 1953 applies.\n\nTHE SCHEDULE\n\nEthinyloestradiol\n\n\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\n\nDated this 11th day of April 1997.\n\nD. GRAHAM\n\nAssistant Secretary\n\nPharmaceutical Benefits Branch\n\nDepartment of Health and Family Services\n\nDelegate of the Minister for Health and Family Services","sortOrder":0}],"analysis":{"kimi_summary":{"_metrics":{"model":"kimi-k2.5","source":"moonshot-batch","completionTokens":1991},"content_quality":"ok","complexity_score":1,"scope_assessment":{"changed":false,"description":"This declaration performs exactly the standard administrative function authorised by section 85(2AA) of the National Health Act 1953: removing a specific drug from the Pharmaceutical Benefits Scheme following expert committee advice. The scope has not expanded beyond this routine delisting process."},"complexity_factors":["Extremely short - less than 250 words total","Single drug listed in the Schedule (Ethinyloestradiol)","No defined terms or interpretation section","Single operative provision with no conditions, exceptions, or nested logic","Minimal cross-referencing (only to the empowering section 85(2AA))"],"plain_english_summary":"This declaration removes ethinyloestradiol — a synthetic estrogen used in contraceptives and HRT — from Australia’s Pharmaceutical Benefits Scheme. From 1 May 1997 patients will no longer receive PBS subsidy for this drug and will pay the full private price unless switched to a subsidised alternative.\n\nThe decision was made by a Department of Health delegate, acting for the Minister and following mandatory PBAC advice, and legally removes the drug from Part VII of the National Health Act 1953."}},"importantCases":[],"_links":{"self":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-6-of-1997","history":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-6-of-1997/history","analysis":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-6-of-1997/analysis","conflicts":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-6-of-1997/conflicts","importantCases":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-6-of-1997/important-cases","documents":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-6-of-1997/documents"}}